Henry Schein, Inc. (HSIC) Position Raised by FDx Advisors Inc.

FDx Advisors Inc. raised its position in Henry Schein, Inc. (NASDAQ:HSIC) by 242.6% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 10,200 shares of the company’s stock after buying an additional 7,223 shares during the quarter. FDx Advisors Inc.’s holdings in Henry Schein were worth $836,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently modified their holdings of HSIC. Eads & Heald Investment Counsel grew its holdings in Henry Schein by 0.5% during the second quarter. Eads & Heald Investment Counsel now owns 1,497 shares of the company’s stock worth $274,000 after acquiring an additional 8 shares during the period. Intrust Bank NA boosted its position in Henry Schein by 1.1% during the second quarter. Intrust Bank NA now owns 1,219 shares of the company’s stock worth $223,000 after purchasing an additional 13 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS boosted its position in Henry Schein by 0.3% during the second quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 5,894 shares of the company’s stock worth $1,079,000 after purchasing an additional 19 shares in the last quarter. YorkBridge Wealth Partners LLC boosted its position in Henry Schein by 5.2% during the second quarter. YorkBridge Wealth Partners LLC now owns 570 shares of the company’s stock worth $104,000 after purchasing an additional 28 shares in the last quarter. Finally, Sawtooth Solutions LLC boosted its position in Henry Schein by 2.4% during the second quarter. Sawtooth Solutions LLC now owns 1,347 shares of the company’s stock worth $247,000 after purchasing an additional 32 shares in the last quarter. Institutional investors own 53.07% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Henry Schein, Inc. (HSIC) Position Raised by FDx Advisors Inc.” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this story on another site, it was illegally stolen and reposted in violation of international copyright legislation. The legal version of this story can be viewed at https://www.dispatchtribunal.com/2017/11/17/henry-schein-inc-hsic-position-raised-by-fdx-advisors-inc.html.

Henry Schein, Inc. (NASDAQ HSIC) opened at $69.51 on Friday. The company has a quick ratio of 0.86, a current ratio of 1.55 and a debt-to-equity ratio of 0.30. The stock has a market capitalization of $10,668.19, a price-to-earnings ratio of 19.07, a P/E/G ratio of 1.91 and a beta of 1.03. Henry Schein, Inc. has a 1-year low of $65.28 and a 1-year high of $93.50.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Monday, November 6th. The company reported $0.87 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.90 by ($0.03). The company had revenue of $3.16 billion during the quarter, compared to analyst estimates of $3.05 billion. Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. The business’s revenue was up 10.3% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.84 earnings per share. analysts anticipate that Henry Schein, Inc. will post 3.6 earnings per share for the current fiscal year.

Henry Schein announced that its Board of Directors has approved a stock buyback program on Monday, September 18th that allows the company to repurchase $400.00 million in shares. This repurchase authorization allows the company to buy up to 6.3% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s leadership believes its stock is undervalued.

In related news, SVP Paul Rose sold 2,126 shares of Henry Schein stock in a transaction on Wednesday, September 6th. The stock was sold at an average price of $172.51, for a total value of $366,756.26. Following the transaction, the senior vice president now directly owns 17,841 shares in the company, valued at approximately $3,077,750.91. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.19% of the company’s stock.

HSIC has been the subject of several research analyst reports. Credit Suisse Group restated a “hold” rating and set a $87.50 price target on shares of Henry Schein in a research note on Tuesday, August 29th. Piper Jaffray Companies raised Henry Schein from a “neutral” rating to an “overweight” rating in a report on Friday, September 15th. Morgan Stanley began coverage on Henry Schein in a report on Thursday, September 21st. They issued an “equal weight” rating and a $88.00 price target on the stock. UBS AG reissued a “buy” rating on shares of Henry Schein in a report on Friday, September 15th. Finally, Stifel Nicolaus reissued a “hold” rating and issued a $89.00 price target on shares of Henry Schein in a report on Thursday, October 19th. Two investment analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have assigned a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus price target of $89.88.

Henry Schein Company Profile

Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply